Company Announcements

IQE plc: Capital Markets Day

Source: RNS
RNS Number : 8496F
IQE PLC
09 November 2022
 

IQE plc

 

 

Cardiff, UK

9 November 2022

 

 

Capital Markets Day

 

 

 

IQE plc (AIM:  IQE, "IQE" or the "Group"), the leading supplier of compound semiconductor wafer products and advanced material solutions to the global semiconductor industry, is hosting a Capital Markets Day this afternoon where management will set out the Group's future growth strategy.

At the core of IQE's refreshed strategy are the following guiding principles: we are market led; we will capture value for what we do; and we will scale and grow our business.

We will achieve this success by using our world-leading capabilities to deliver solutions to our customers that connect, power, sense and display across the following three growth markets:

1)   Smart connected devices

2)   Communications infrastructure

3)   Automotive and industrial

The global epiwafer market is forecast to grow by 22% CAGR to $4.6bn in 2027*, and IQE will continue to focus on its existing markets, related to Wireless and Photonics, while diversifying into power electronics and microLED display markets.

IQE is now targeting growth of 3x anticipated revenues in 2022 in five years' time. This represents a target of ~$650m revenue in 2027. This growth is underpinned by strategic long-term agreements, long-term commitments both to and from IQE's customers, and a collaborative approach to co-investment alongside its customers.  The Group intends to invest alongside its customers both tactically, for R&D to develop new products, and strategically, tripling reactor capacity to facilitate mass production and the achievement of economies of scale. This collaborative approach to both R&D and manufacturing investment reduces the Group's technical and financial risk whilst helping to maintain its leading edge technology advantage.

Growth is targeted to be delivered across each product capability by 2027:

Product capability

Target growth rate

Target revenue

Target market share

Connect

15% CAGR

> $175m

c. 20%

Sense

15% CAGR

>$225m

c. 20%

Power

-

>$150m

c. 10%

Display

>56%

>$50m

c. 20%

 

It is also expected that this revenue growth, together with the operational gearing of the Group, IQE's plans to further optimise its global footprint, plus the deployment of a transformed commercial model, will result in significant margin expansion. Therefore, the Group is targeting an EBITDA margin of over 30% by 2027.

The full programme of Capital Markets Day presentations can be viewed at cmd.iqep.com.

Americo Lemos, Chief Executive Officer of IQE, commented:

"I am delighted to present IQE's first Capital Markets Day in four years. Since joining as CEO in January, my view has been reinforced, that IQE has a significant market opportunity, as well as the people, technology and manufacturing assets upon which to capitalise on that opportunity. By pivoting our commercial model to become market-led and focussing on scaling and growing our business while capturing value for our shareholders, we can now set an ambitious and actionable target for growth over the next five years."

* Source: Yole Group and IQE sources

Contacts:

 

IQE plc

+44 (0) 29 2083 9400

Americo Lemos

Tim Pullen

Amy Barlow

           

Peel Hunt LLP (Nomad and Joint Broker)

+44 (0) 20 7418 8900

Paul Gillam

James Smith

           

Numis (Joint Broker)

+44 (0) 20 7260 1000

Simon Willis

Hugo Rubinstein

Iqra Amin

 

Headland Consultancy (Financial PR)
+ 44 (0) 20 38054822

Andy Rivett-Carnac: +44 (0) 7968 997 365

Antonia Pollock: +44 (0) 7789 954 356

Marta Parry-Jones: +44 (0) 7884742400

 

ABOUT IQE

http://iqep.com

 

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

 

·    handset devices

·    global telecoms infrastructure

·    connected devices

·    3D sensing

 

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group's intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.


IQE is headquartered in Cardiff UK, with c. 685 employees across eight manufacturing locations in the UK, US and Taiwan, and is listed on the AIM Stock Exchange in London.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBKLFBLFLEFBQ